Product
Topical H2R Antagonist
1 clinical trial
1 indication
Indication
MelasmaClinical trial
The Efficacy in Treatment of Facial Melasma Combined With Thulium 1927-nm Fractional Laser and Topical H2R Antagonist: a Split-face, Single-blind StudyStatus: Completed, Estimated PCD: 2023-11-25